Find and Share Events with Friends 🥳
x
Advanced PET Imaging, Nuclear Medicine, and Therapy: From Diagnostics to Theranostics promotional image
Company Profile Image

Advanced PET Imaging, Nuclear Medicine, and Therapy: From Diagnostics to Theranostics

Conference

What’s Happening?

This course provides a clinical perspective of PET/CT imaging and the emerging use of Theranostic agents within Nuclear Medicine. A broad perspective on the economic, clinical, and academic aspects of the latest trends in PET/CT imaging and Nuclear Medicine therapy will be presented.
At the conclusion of this course, participants will be able to:
- Describe new developments in the merger of diagnostic and therapeutic radioligands for PET/CT imaging and therapy with specific focus on DOTA, PSMA, and PRRT
- Describe the logistics of bringing these new diagnostic and therapeutic technologies to clinical practice
- Identify the key clinical indications for new emerging tracers for Neuroendocrine Tumor and Prostate cancer using somatostatin receptor and PSMA PET/CT imaging
- Review and discuss the standard-of-care clinical application and advanced interpretation of FDG PET/CT


URLs:
Website: https://go.evvnt.com/3669339-0?pid=11150
Virtual: https://go.evvnt.com/3669339-3?pid=11150

Venue details: Online

Prices:
Standard Registration-Physicians MD/DO: USD 1495.00,
Nurses/Advanced Practice Professionals/Retired/Active Military: USD 1395.00,
Radiologic Technologists/Residents/Fellows: USD 1295.00


Speakers: Phillip Kuo, MD, PhD, FACR, Don C. Yoo, MD

This course provides a clinical perspective of PET/CT imaging and the emerging use of Theranostic agents within Nuclear Medicine. A broad perspective on the economic, clinical, and academic aspects of the latest trends in PET/CT imaging and Nuclear Medicine therapy will be presented.
At the conclusion of this course, participants will be able to:
- Describe new developments in the merger of diagnostic and therapeutic radioligands for PET/CT imaging and therapy with specific focus on DOTA, PSMA, and PRRT
- Describe the logistics of bringing these new diagnostic and therapeutic technologies to clinical practice
- Identify the key clinical indications for new emerging tracers for Neuroendocrine Tumor and Prostate cancer using somatostatin receptor and PSMA PET/CT imaging
- Review and discuss the standard-of-care clinical application and advanced interpretation of FDG PET/CT


URLs:
Website: https://go.evvnt.com/3669339-0?pid=11150
Virtual: https://go.evvnt.com/3669339-3?pid=11150

Venue details: Online

Prices:
Standard Registration-Physicians MD/DO: USD 1495.00,
Nurses/Advanced Practice Professionals/Retired/Active Military: USD 1395.00,
Radiologic Technologists/Residents/Fellows: USD 1295.00


Speakers: Phillip Kuo, MD, PhD, FACR, Don C. Yoo, MD

When & Where
Oct 22, 2026, 7:30am to
Oct 23, 2026, 4:45pm Timezone: PDT
$1,295.00


More events from EVVNT